Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
364-02-005 ISMRM Abstract

Poor Baseline Brain Reserve Increases Mortality Risk in Glioblastoma

Accepted
Sree Gongala1, Robin S Ghotra1,2, George Wang3,4, Jose A Garcia5,6, Rubo Xing7, Parisa Arjmand1, Pamela LaMontagne8, Josep Puig9, Danial Marcus8, Yilun Sun10,11, Haley Perlow12,13, Tiffany R Hodges14, Christos Davatzikos5,6,7, Chaitra Badve 2
1Department of Radiology, Case Western Reserve University, Cleveland, United States of America
2Department of Radiology, University Hospitals, Cleveland, United States of America
3Department of Radiology, Case Western Reserve University School of Medicine, Cleveland, United States of America
4Case Western Reserve University School of Medicine, Cleveland, United States of America
5Center for Biomedical Image Computing and Analytics (CBICA), University of Pennsylvania, Philadelphia, United States of America
6Department of Radiology, Division of Neuroradiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America
7Center for AI and Data Science for Integrated Diagnostics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America
8Department of Radiology, Washington University School of Medicine, St. Louis, United States of America
9Badalona Applied Research Group in Oncology (B-ARGO Group), Barcelona, Spain
10Case Western Reserve University, Cleveland, United States of America
11Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, United States of America
12Department of Radiation Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America
13Department of Radiation Oncology, University Hospitals, Cleveland, United States of America
14Department of Neurological Surgery, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio, United States of America
Presenting Author: Chaitra Badve

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. 1. Price M, Ballard C, Benedetti J, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS, Ostrom QT. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021. Neuro Oncol. 2024 Oct 6;26(Supplement_6):vi1-vi85. doi: 10.1093/neuonc/noae145. PMID: 39371035; PMCID: PMC11456825. [doi] [pmid]
2. 2. Zarnett OJ, Sahgal A, Gosio J, Perry J, Berger MS, Chang S, et al. Treatment of Elderly Patients With Glioblastoma: A Systematic Evidence-Based Analysis. JAMA Neurol. 2015 May;72(5):589-96. doi: 10.1001/jamaneurol.2014.3739. PMID: 25822375. [doi] [pmid]
3. 3. Arakawa Y, Mineharu Y, Uto M, Mizowaki T. Optimal managements of elderly patients with glioblastoma. Jpn J Clin Oncol. 2022 Nov 3;52(11):1358. doi: 10.1093/jjco/hyac156. PMID: 35552425; PMCID: PMC9841411. [doi] [pmid]
4. 4. Pettemeridou E, Kallousia E, Constantinidou F. Regional Brain Volume, Brain Reserve and MMSE Performance in Healthy Aging From the NEUROAGE Cohort: Contributions of Sex, Education, and Depression Symptoms. Front Aging Neurosci. 2021 Nov 12;13:711301. doi: 10.3389/fnagi.2021.711301. PMID: 34867265; PMCID: PMC8633314. [doi] [pmid]
5. 5. Yamada M, Takechi H, Mori S, Aoyama T, Arai H. Global brain atrophy is associated with physical performance and the risk of falls in older adults with cognitive impairment. Geriatr Gerontol Int. 2013 Apr;13(2):437-42. doi: 10.1111/j.1447-0594.2012.00927.x. Epub 2012 Aug 31. PMID: 22935103. [doi] [pmid]
6. 6. Burns JM, Cronk BB, Anderson HS, Donnelly JE, Thomas GP, Harsha A, et al. Cardiorespiratory Fitness and Brain Atrophy in Early Alzheimer’s Disease. Neurology. 2008 Jul 15;71(3):210-6. doi: 10.1212/01.wnl.0000317094.86209.cb. PMID: 18625967; PMCID: PMC2657657. [doi] [pmid]
7. 7. Stern Y, Barnes CA, Grady C, Jones RN, Raz N. Brain reserve, cognitive reserve, compensation, and maintenance: operationalization, validity, and mechanisms of cognitive resilience. Neurobiol Aging. 2019 Nov;83:124-129. doi: 10.1016/j.neurobiolaging.2019.03.022. PMID: 31732015; PMCID: PMC6859943. [doi] [pmid]
8. 8. Lamichhane B, Luckett PH, Dierker D, Yun Park K, Burton H, Olufawo M, et al. Structural gray matter alterations in glioblastoma and high-grade glioma—A potential biomarker of survival. Neuro-Oncol Adv. 2023 Apr 14;5(1):vdad034. doi: 10.1093/noajnl/vdad034. PMID: 37152811; PMCID: PMC10162111. [doi] [pmid]
9. 9. Lorimer C, Mills S, Chalmers A, Coombes I, Thompson G, Glendenning J, et al. Baseline total brain volume predicts changes in quality of life and overall survival after cranial radiotherapy in older patients with glioblastoma: Results from the prospective BRITER study. Neuro-Oncol Pract. 2024 Mar 9;11(4):413-420. doi: 10.1093/nop/npae019. PMID: 39006523; PMCID: PMC11241370. [doi] [pmid]
10. 10. Davatzikos C, Barnholtz-Sloan JS, Bakas S, Colen R, Mahajan A, Quintero CB, et al. AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium. Neuro-Oncol. 2020 Jun 9;22(6):886-888. doi: 10.1093/neuonc/noaa045. PMID: 32152622; PMCID: PMC7283022. [doi] [pmid]
11. 11. Davatzikos C, Rathore S, Bakas S, Pati S, Bergman M, Kalarot R, et al. Cancer imaging phenomics toolkit: quantitative imaging analytics for precision diagnostics and predictive modeling of clinical outcome. J Med Imaging. 2018 Jan 11. PMID: 29340286; PMCID: PMC5764116. [pmid]
12. 12. Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E, The Alzheimer's Disease Neuroimaging Initiative. CAT: a computational anatomy toolbox for the analysis of structural MRI data. Gigascience. 2024 Jan 2;13:giae049. doi: 10.1093/gigascience/giae049. PMID: 39102518; PMCID: PMC11299546. [doi] [pmid]
13. 13. Yuan T, Zuo Z, Ying J, Jin L, Kang J, Gui S, et al. Structural and Functional Alterations in the Contralesional Medial Temporal Lobe in Glioma Patients. Front Neurosci. 2020 Feb 20;14:10. doi: 10.3389/fnins.2020.00010. PMID: 32153348; PMCID: PMC7044242. [doi] [pmid]
14. 14. Lamballais S, Vinke EJ, Vernooij MW, Ikram MA, Muetzel RL. Cortical gyrification in relation to age and cognition in older adults. NeuroImage. 2020 May 15;212:116637. doi: 10.1016/j.neuroimage.2020.116637. Epub 2020 Feb 17. PMID: 32081782. [doi] [pmid]
15. 15. Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Hanscom BS, et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat. 2008 Jul;110(1):143-52. doi: 10.1007/s10549-007-9686-5. Epub 2007 Aug 3. PMID: 17674194; PMCID: PMC3114441. [doi] [pmid]
16. 17. Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 2005 Aug 15;104(4):788-93. doi: 10.1002/cncr.21234. PMID: 15973668. [doi] [pmid]
17. 18. Jankaew A, Chen PS, Lin CF. Decline in physical function is associated with cognitive impairment and quality of life in pancreatic cancer patients undergoing chemotherapy. Arch Phys Med Rehabil. 2025 Apr 1;106(4):e16–7. doi:10.1016/j.apmr.2025.01.042. [doi]

Cite this abstract